The PE Ratio as of June 2026 (TTM) for Grace Therapeutics, Inc. (GRCE) is -7.10

According to Grace Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.10. This represents a change of 281.37% compared to the average of -1.86 of the last 4 quarters.

Grace Therapeutics, Inc. (GRCE) Historical PE Ratio (quarterly & annually)

How has GRCE PE Ratio performed in the past?

The mean historical PE Ratio of Grace Therapeutics, Inc. over the last ten years is -0.65. The current -7.10 PE Ratio has changed 109.25% with respect to the historical average. Over the past ten years (40 quarters), GRCE's PE Ratio was at its highest in in the March 2025 quarter at 8.81. The PE Ratio was at its lowest in in the September 2025 quarter at -9.07.

Grace Therapeutics, Inc. (GRCE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Grace Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Grace Therapeutics, Inc. (GRCE) Average PE Ratio

How has GRCE PE Ratio performed in the past?

The current PE Ratio of Grace Therapeutics, Inc. (GRCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Grace Therapeutics, Inc. (GRCE) PE Ratio vs. Peers

How is GRCE’s PE Ratio compared to its peers?

Grace Therapeutics, Inc.’s PE Ratio is less than LAVA Therapeutics N.V. (-2.01), less than Tvardi Therapeutics, Inc. (-1.60), less than Actinium Pharmaceuticals, Inc. (-1.34), less than PDS Biotechnology Corporation (-1.75), less than CalciMedica, Inc. (-0.67), greater than Xilio Therapeutics, Inc. (-43.40), less than Lantern Pharma Inc. (-2.74), less than OnKure Therapeutics, Inc. (-0.98), less than RenovoRx, Inc. (-2.62), less than ABVC BioPharma, Inc. (-3.21),

Build a custom stock screener for Grace Therapeutics, Inc. (GRCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grace Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Grace Therapeutics, Inc. (GRCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Grace Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.